Wed, Aug 20, 2014, 11:55 AM EDT - U.S. Markets close in 4 hrs 5 mins


% | $
Quotes you view appear here for quick access.

Cyclacel Pharmaceuticals, Inc. (CYCC) Message Board

  • redstenox redstenox Dec 3, 2012 11:17 AM Flag

    ►► CYCC (exceptional price target) ◄◄

    CYCC's average Wall Street 12-month SP calculation is $17.50 (nearly a triple on a reverse split adjusted basis), which I believe fair if there is no partner catalyst within the next 12 months. However, if some news enters on the bus-dev front in 2013, a triple could get to $25 pretty quickly.

    The above from today's Seeking Alpha article. Looks like they've done some homework on this one too.

    Nov 1, 2012 recent HOD $7.77 and on Oct 15, 2012 a $7.93 HOD given the corrections on large surges has occurred buying in under $6 is a gift horse. Never look one in the mouth.

    MARKET OUTPERFORM price target $25 inline for the triple sighted above.

    Investors will probably agree with this review using their due diligence/fact checking.


    SortNewest  |  Oldest  |  Most Replied Expand all replies
3.14-0.01(-0.32%)11:50 AMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.